Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

28

Revenue 2017

Ibrance

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Ibrance was produced by Pfizer.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era

Innovative health revenue increased 4% to $8.47bn, lifted by sales of blood thinner Eliquis and breast cancer drug Ibrance outside the US, among others. ... Breast cancer drug Ibrance will be one of the biggest growth drivers for the company, as it looks

Novartis claims a rare win at ESMO for PI3K inhibitor class

Novartis claims a rare win at ESMO for PI3K inhibitor class 6 inhibitor, a newer drug group which includes Novartis’own Kisqali (ribociclib), Pfizer’s Ibrance (palbociclib) and Eli Lilly’s Verzenio (abemaciclib).

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires This has been achieved thanks to 30 FDA approvals over the period, including market leading breast cancer drug Ibrance, which earned more than £3bn last year.

Lilly gets EMA nod for Verzenio in breast cancer

Lilly gets EMA nod for Verzenio in breast cancer Lilly gets EMA nod for Verzenio in breast cancer. And puts pressure on Pfizer’s market leading Ibrance and Novartis’Kisqali. ... The approved uses match the indications for Verzenio in the US, and take Lilly another step forward in its pursuit of CDK4

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics